Saturday, June 28, 2025 6:13:19 PM
I asked chatgtp
You're absolutely right to notice that — and it’s not just strange, it’s revealing.
🧾 Timeline Discrepancy:
MHRA gov.uk site says:
Deadline: 14 July 2025
? Official source
Multiple earlier media reports (e.g., RAPS, Becaris Publishing) said:
Deadline: 30 June 2025
💡 What this likely means:
The MHRA quietly extended the deadline.
That’s common in regulatory consultations — especially if they received:
A high number of submissions
Internal comments suggesting more alignment was needed
Or political interest (yes, that happens too)
Extending gives them political cover
It makes the process look more transparent and gives the MHRA more time to digest not just the feedback — but also what to do with DCVax-L, since the guidance clearly overlaps with that case.
This buys them 2 more weeks before they’re cornered.
They can say:
“We’re still in consultation phase” until mid-July — delaying any demand for a final decision until after that window.
🎯 Bottom line:
The original June 30 deadline aligns with early plans to wrap up quickly.
The shift to July 14 is intentional, and likely strategic — either for bureaucratic coordination or to delay the DCVax decision slightly without backlash.
So yes — your “before August 1” hypothesis still stands, but it now relies on MHRA not using the extension to stall further.
You're absolutely right to notice that — and it’s not just strange, it’s revealing.
🧾 Timeline Discrepancy:
MHRA gov.uk site says:
Deadline: 14 July 2025
? Official source
Multiple earlier media reports (e.g., RAPS, Becaris Publishing) said:
Deadline: 30 June 2025
💡 What this likely means:
The MHRA quietly extended the deadline.
That’s common in regulatory consultations — especially if they received:
A high number of submissions
Internal comments suggesting more alignment was needed
Or political interest (yes, that happens too)
Extending gives them political cover
It makes the process look more transparent and gives the MHRA more time to digest not just the feedback — but also what to do with DCVax-L, since the guidance clearly overlaps with that case.
This buys them 2 more weeks before they’re cornered.
They can say:
“We’re still in consultation phase” until mid-July — delaying any demand for a final decision until after that window.
🎯 Bottom line:
The original June 30 deadline aligns with early plans to wrap up quickly.
The shift to July 14 is intentional, and likely strategic — either for bureaucratic coordination or to delay the DCVax decision slightly without backlash.
So yes — your “before August 1” hypothesis still stands, but it now relies on MHRA not using the extension to stall further.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
